The World Health Organization (WHO) has formally thrown its support behind Nigeria’s intensified efforts to curb the rising epidemic of drug misuse across the country. This endorsement comes at a crucial time as the federal government actively seeks a balanced approach to tackle substance abuse among its citizens, particularly the youth, while simultaneously ensuring that patients with legitimate medical needs have uninterrupted access to essential, controlled medications.
According to an official statement released by the global health body, Nigeria is taking proactive and highly commendable national actions to safeguard its communities and younger demographics from the devastating impacts of drug addiction.
The public health crisis in Nigeria has been exacerbated in recent years by the rampant misuse of controlled substances, particularly prescription opioids like tramadol and codeine-based cough syrups. This widespread challenge has not only triggered severe mental health issues but has also been directly linked to escalating cases of insecurity, violence, and socio-economic instability across various regions of the country.
The WHO’s validation followed the successful conclusion of the National Drug Use Summit in Abuja. This high-level conference was collaboratively organized by the Federal Ministry of Health and Social Welfare, the National Drug Law Enforcement Agency (NDLEA), and the United Nations in Nigeria, with critical financial and structural support from international partners, including the Global Fund.
The summit brought together key government leaders, security officials, healthcare experts, and civil society groups with the unified goal of advancing the implementation of the National Drug Control Master Plan.
A major breakthrough of the summit was the endorsement of a joint communique aimed at strengthening the core pillars of Nigeria’s strategic drug control framework. The new consensus targets a highly cooperative, “whole-of-society” strategy.
This strategy aims to dismantle illegal drug trafficking cartels and scale up public rehabilitation programs while ensuring that critical painkillers, palliative care drugs, and mental health medicines remain safely available to the hospitals and patients who truly need them.